Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29)
Open Access
- 1 March 2008
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 153 (5), 870-878
- https://doi.org/10.1038/sj.bjp.0707634
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Celecoxib for the Prevention of Colorectal Adenomatous PolypsThe New England Journal of Medicine, 2006
- Targeting the beta‐catenin/APC pathway: a novel mechanism to explain the cyclooxygenase‐2‐independent anticarcinogenic effects of celecoxib in human colon carcinoma cellsThe FASEB Journal, 2005
- Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endotheliumInternational Journal of Cancer, 2004
- Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugsInternational Journal of Cancer, 2004
- Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skinCarcinogenesis: Integrative Cancer Research, 2003
- Substance P increases neutrophil adhesion to human umbilical vein endothelial cellsBritish Journal of Pharmacology, 2003
- Using Cyclooxygenase-2 Inhibitors as Molecular Platforms to Develop a New Class of Apoptosis-Inducing AgentsJNCI Journal of the National Cancer Institute, 2002
- The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of actionEuropean Journal of Cancer, 2000
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Leukocyte integrinsCurrent Opinion in Cell Biology, 1995